Laura Torres Juan

Prof. Laura Torres Juan

IDISBA (Instituto de Investigación de las Islas Baleares), Palma de Mallorca, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2007 in European Journal of Human Genetics
Verified
Journal Article
Closed access
LJLaura Torres Juan
Laura Torres Juan
JRJordi Rosell
Jordi Rosell
MMMontse Morla
Montse Morla
CVCatalina Vidal-Pou
Catalina Vidal-Pou
FGFernando García-Algas
Fernando García-Algas
DSDamian Heine Suñer
Damian Heine Suñer

14 July 2003 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
DSDamian Heine Suñer
Damian Heine Suñer
LJLaura Torres Juan
Laura Torres Juan
MMM. Morlà
M. Morlà
XBXavier Busquets
Xavier Busquets
FBF. Barceló
F. Barceló
JRJ. Rosell
J. Rosell

2 April 2007 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
LJLaura Torres Juan
Laura Torres Juan
JRJordi Rosell
Jordi Rosell
MSManuel Sánchez-de-la-Torre
Manuel Sánchez-de-la-Torre
JFJoan Fibla
Joan Fibla
DSDamian Heine Suñer
Damian Heine Suñer
Background: The 22q11.2 deletion syndrome is the most frequent genomic disorder with an estimated frequency of 1/4000 live births. The majority of patients (90%) have the same deletion of 3 Mb (Typically Deleted Region, TDR) that results from aberrant recombination at meiosis between region specific low-copy repeats (LCRs). Methods: As a first step towards the characterization of recombination rates and breakpoints within the 22q11.2 region we have constructed a high resolution recombination breakpoint map based on pedigree analysis and a population-based historical recombination map based on LD analysis. Results: Our pedigree map allows the location of recombination breakpoints with a high resolution (potential recombination hotspots), and this approach has led to the identification of 5 breakpoint segments of 50 kb or less (8.6 kb the smallest), that coincide with historical hotspots. It has been suggested that aberrant recombination leading to deletion (and duplication) is caused by low rates of Allelic Homologous Recombination (AHR) within the affected region. However, recombination rate estimates for 22q11.2 region show that neither average recombination rates in the 22q11.2 region or within LCR22-2 (the LCR implicated in most deletions and duplications), are significantly below chromosome 22 averages. Furthermore, LCR22-2, the repeat most frequently implicated in rearrangements, is also the LCR22 with the highest levels of AHR. In addition, we find recombination events in the 22q11.2 region to cluster within families. Within this context, the same chromosome recombines twice in one family; first by AHR and in the next generation by NAHR resulting in an individual affected with the del22q11.2 syndrome. Conclusion: We show in the context of a first high resolution pedigree map of the 22q11.2 region that NAHR within LCR22 leading to duplications and deletions cannot be explained exclusively under a hypothesis of low AHR rates. In addition, we find that AHR recombination events cluster within families. If normal and aberrant recombination are mechanistically related, the fact that LCR22s undergo frequent AHR and that we find familial differences in recombination rates within the 22q11.2 region would have obvious health-related implications.

2 April 2008 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
LFLuis Fernández
Luis Fernández
PLPablo Lapunzina
Pablo Lapunzina
IPIsidora López Pajares
Isidora López Pajares
MBMaria Palomares Bralo
Maria Palomares Bralo
IMIsabel Martínez
Isabel Martínez
ADAlicia Delicado
Alicia Delicado

1 July 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
PMPaula Morlanes-Gracia
Paula Morlanes-Gracia
GAGuido Antoniutti
Guido Antoniutti
JAJorge Alvarez-Rubio
Jorge Alvarez-Rubio
LJLaura Torres Juan
Laura Torres Juan
DSDamian Heine Suñer
Damian Heine Suñer
TRTomás Ripoll-Vera
Tomás Ripoll-Vera
The NKX2-5 gene encodes for a transcription factor crucial for cardiac cell differentiation and proliferation. It was the first gene associated with congenital heart disease (CHD) in humans and has been linked to conduction disorders or cardiomyopathies. However, an overlapping phenotype is not frequent in the literature. We describe a family with a novel missense mutation in the NKX2-5 gene (p.Gln181Pro) with numerous antecedents with atrial septal defect (ASD), left ventricular non-compaction (LVNC), conduction disease, and sudden cardiac death (SCD).

1 September 2007
Verified
Journal Article
Closed access
XBXavier Busquets
Xavier Busquets
NMNiall G MacFarlane
Niall G MacFarlane
DSDamian Heine Suñer
Damian Heine Suñer
MMMontse Morlá
Montse Morlá
LJLaura Torres Juan
Laura Torres Juan
AAAlvar Agustí
Alvar Agustí